Literature DB >> 21754831

7,9-Bis(hy-droxy-meth-yl)-7H-purine-2,6,8(1H,3H,9H)trione.

M Daudon, D Bazin, K Adil, A Le Bail.   

Abstract

The structure of the title uric acid derivative, C(7)H(8)N(4)O(5), from human kidney stones, is characterized by the C and O atoms of one of the two hy-droxy-methyl groups being disordered nearly equally over three different sites. In the crystal, mol-ecules are connected by a three-dimensional hydrogen-bonding scheme though they look stacked in planes nearly parallel to ([Formula: see text]04).

Entities:  

Year:  2011        PMID: 21754831      PMCID: PMC3120625          DOI: 10.1107/S1600536811018186

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For related structures, see: Ringertz (1966 ▶) for uric acid and Parkin & Hope (1998 ▶) for the dihydrate. For urolithia­sis, see: Tanagho & McAninch (2000 ▶); Jungers et al. (2005 ▶); Moe (2006 ▶); Knoll (2007 ▶). For recent characterization of new urinary stones, see: Le Bail et al. (2009 ▶); For purine biosynthesis, see: Ashihara et al. (2008 ▶). For hy­droxy­methyl­ation of uric acid, see: Lubczak et al. (2002 ▶).

Experimental

Crystal data

C7H8N4O5 M = 228.17 Monoclinic, a = 5.3226 (6) Å b = 11.5541 (13) Å c = 14.5931 (18) Å β = 97.340 (7)° V = 890.09 (18) Å3 Z = 4 Mo Kα radiation μ = 0.15 mm−1 T = 150 K 0.22 × 0.12 × 0.06 mm

Data collection

Bruker Kappa APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2008 ▶) T min = 0.677, T max = 0.746 33302 measured reflections 3075 independent reflections 2127 reflections with I > 2σ(I) R int = 0.064

Refinement

R[F 2 > 2σ(F 2)] = 0.056 wR(F 2) = 0.166 S = 1.03 3075 reflections 169 parameters 1 restraint H-atom parameters constrained Δρmax = 0.78 e Å−3 Δρmin = −0.37 e Å−3 Data collection: APEX2 (Bruker, 2008 ▶); cell refinement: SAINT (Bruker, 2008 ▶) and McMaille (Le Bail, 2004 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶) and ESPOIR (Le Bail, 2001 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: DIAMOND (Brandenburg, 2001 ▶) and ORTEP-3 (Farrugia, 1997 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811018186/zl2370sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811018186/zl2370Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811018186/zl2370Isup3.mol Supplementary material file. DOI: 10.1107/S1600536811018186/zl2370Isup4.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C7H8N4O5F(000) = 472.0
Mr = 228.17Dx = 1.703 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 241 reflections
a = 5.3226 (6) Åθ = 4–15°
b = 11.5541 (13) ŵ = 0.15 mm1
c = 14.5931 (18) ÅT = 150 K
β = 97.340 (7)°Fragment, pale-green
V = 890.09 (18) Å30.22 × 0.12 × 0.06 mm
Z = 4
Bruker Kappa APEXII CCD diffractometer3075 independent reflections
Radiation source: fine-focus sealed tube2127 reflections with I > 2σ(I)
graphiteRint = 0.064
ω scans; 30 settingsθmax = 32.3°, θmin = 3.5°
Absorption correction: multi-scan (SADABS; Bruker, 2008)h = −7→7
Tmin = 0.677, Tmax = 0.746k = −17→17
33302 measured reflectionsl = −21→21
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.056Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.166H-atom parameters constrained
S = 1.03w = 1/[σ2(Fo2) + (0.0816P)2 + 0.5575P] where P = (Fo2 + 2Fc2)/3
3075 reflections(Δ/σ)max < 0.001
169 parametersΔρmax = 0.78 e Å3
1 restraintΔρmin = −0.37 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
O21.0659 (2)−0.20036 (10)0.35524 (10)0.0250 (3)
O61.3617 (2)0.14185 (10)0.48924 (9)0.0241 (3)
O80.5565 (3)0.35248 (12)0.28547 (13)0.0430 (4)
O90.2229 (2)0.11073 (11)0.19866 (10)0.0278 (3)
H90.10800.18300.18600.042*
N11.2092 (3)−0.02650 (11)0.41726 (10)0.0174 (3)
H11.3389−0.06200.44580.021*
N30.8444 (3)−0.03560 (11)0.30815 (10)0.0175 (3)
H30.7360−0.07400.27390.021*
N70.8876 (3)0.26000 (12)0.37849 (11)0.0247 (3)
N90.6403 (3)0.15297 (12)0.27429 (11)0.0224 (3)
C21.0404 (3)−0.09345 (13)0.35937 (11)0.0167 (3)
C40.8172 (3)0.08053 (13)0.32201 (11)0.0162 (3)
C50.9722 (3)0.14401 (13)0.38595 (11)0.0165 (3)
C61.1933 (3)0.09272 (13)0.43511 (11)0.0161 (3)
C80.6827 (4)0.26569 (15)0.31068 (14)0.0273 (4)
C90.4761 (3)0.12956 (15)0.18565 (13)0.0236 (4)
H9A0.48500.19620.14350.028*
H9B0.54070.06060.15590.028*
C7A0.9677 (4)0.35741 (15)0.44018 (14)0.0268 (4)0.339 (3)
H7A11.13760.34280.47440.032*0.339 (3)
H7A20.97340.43010.40450.032*0.339 (3)
O710.7889 (9)0.3644 (4)0.4997 (3)0.0325 (11)0.339 (3)
H710.81730.31340.54070.049*0.339 (3)
C7B0.9677 (4)0.35741 (15)0.44018 (14)0.0268 (4)0.340 (6)
H7B10.81660.39020.46380.032*0.340 (6)
H7B21.08230.32780.49380.032*0.340 (6)
O721.0842 (9)0.4407 (3)0.4008 (3)0.0244 (13)0.340 (6)
H720.97640.48470.37170.037*0.340 (6)
C7C0.9677 (4)0.35741 (15)0.44018 (14)0.0268 (4)0.321 (6)
H7C10.97600.33220.50530.032*0.321 (6)
H7C20.84240.42090.42980.032*0.321 (6)
O731.2214 (10)0.3999 (4)0.4221 (4)0.0344 (15)0.321 (6)
H731.25690.37170.37230.052*0.321 (6)
U11U22U33U12U13U23
O20.0232 (6)0.0108 (5)0.0381 (7)0.0017 (4)−0.0069 (5)−0.0015 (5)
O60.0215 (6)0.0168 (5)0.0301 (7)0.0027 (4)−0.0114 (5)−0.0047 (5)
O80.0344 (8)0.0159 (6)0.0700 (11)0.0077 (5)−0.0270 (8)−0.0004 (6)
O90.0188 (6)0.0212 (6)0.0422 (8)−0.0021 (5)−0.0010 (5)0.0016 (5)
N10.0157 (6)0.0121 (6)0.0224 (7)0.0027 (5)−0.0051 (5)0.0001 (5)
N30.0161 (6)0.0106 (6)0.0237 (7)−0.0005 (5)−0.0057 (5)−0.0006 (5)
N70.0221 (7)0.0125 (6)0.0355 (8)0.0039 (5)−0.0117 (6)−0.0033 (5)
N90.0200 (7)0.0122 (6)0.0313 (8)0.0000 (5)−0.0113 (6)0.0023 (5)
C20.0152 (7)0.0126 (6)0.0211 (7)0.0003 (5)−0.0019 (6)0.0008 (5)
C40.0135 (7)0.0127 (6)0.0209 (7)−0.0001 (5)−0.0030 (5)0.0020 (5)
C50.0158 (7)0.0113 (6)0.0211 (7)0.0019 (5)−0.0027 (6)0.0001 (5)
C60.0159 (7)0.0134 (6)0.0179 (7)0.0010 (5)−0.0016 (5)−0.0001 (5)
C80.0231 (9)0.0147 (7)0.0397 (10)0.0022 (6)−0.0129 (8)−0.0005 (7)
C90.0204 (8)0.0193 (8)0.0282 (9)−0.0016 (6)−0.0078 (7)0.0027 (6)
C7A0.0307 (10)0.0149 (7)0.0329 (9)0.0015 (6)−0.0031 (7)−0.0041 (6)
O710.049 (3)0.024 (2)0.025 (2)0.0127 (18)0.0052 (18)0.0001 (15)
C7B0.0307 (10)0.0149 (7)0.0329 (9)0.0015 (6)−0.0031 (7)−0.0041 (6)
O720.022 (2)0.0179 (19)0.032 (2)−0.0022 (16)0.0001 (16)0.0008 (15)
C7C0.0307 (10)0.0149 (7)0.0329 (9)0.0015 (6)−0.0031 (7)−0.0041 (6)
O730.028 (3)0.027 (2)0.048 (3)−0.003 (2)0.002 (2)0.005 (2)
O2—C21.2450 (19)N9—C41.380 (2)
O6—C61.2524 (19)N9—C81.414 (2)
O8—C81.236 (2)N9—C91.491 (2)
O9—C91.401 (2)C4—C51.376 (2)
O9—H91.0371C5—C61.426 (2)
N1—C21.387 (2)C9—H9A0.9900
N1—C61.406 (2)C9—H9B0.9900
N1—H10.8627C7A—O711.371 (5)
N3—C41.3673 (19)C7A—H7A10.9900
N3—C21.377 (2)C7A—H7A20.9900
N3—H30.8402O71—H710.8400
N7—C81.377 (2)O72—H720.8400
N7—C51.414 (2)O73—H730.8400
N7—C7A1.470 (2)
C9—O9—H9114.0C4—C5—C6120.28 (14)
C2—N1—C6127.52 (13)N7—C5—C6131.83 (14)
C2—N1—H1116.4O6—C6—N1120.36 (14)
C6—N1—H1116.1O6—C6—C5127.36 (14)
C4—N3—C2118.90 (13)N1—C6—C5112.28 (13)
C4—N3—H3121.9O8—C8—N7127.05 (17)
C2—N3—H3118.8O8—C8—N9125.52 (16)
C8—N7—C5108.41 (13)N7—C8—N9107.43 (14)
C8—N7—C7A123.00 (14)O9—C9—N9112.21 (16)
C5—N7—C7A127.88 (14)O9—C9—H9A109.2
C4—N9—C8107.66 (13)N9—C9—H9A109.2
C4—N9—C9127.92 (14)O9—C9—H9B109.2
C8—N9—C9122.74 (14)N9—C9—H9B109.2
O2—C2—N3122.35 (14)H9A—C9—H9B107.9
O2—C2—N1121.10 (14)O71—C7A—N7105.2 (2)
N3—C2—N1116.54 (13)O71—C7A—H7A1110.7
N3—C4—C5123.92 (14)N7—C7A—H7A1110.7
N3—C4—N9126.78 (14)O71—C7A—H7A2110.7
C5—C4—N9109.29 (13)N7—C7A—H7A2110.7
C4—C5—N7107.20 (13)H7A1—C7A—H7A2108.8
D—H···AD—HH···AD···AD—H···A
O9—H9···O2i1.041.702.7270 (18)169
N1—H1···O6ii0.861.982.8388 (18)179
N3—H3···O8iii0.841.882.7104 (19)167
O71—H71···O2iv0.842.042.873 (4)172
O72—H72···O9i0.842.012.834 (5)169
O73—H73···O8v0.842.172.892 (6)144
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O9—H9⋯O2i1.041.702.7270 (18)169
N1—H1⋯O6ii0.861.982.8388 (18)179
N3—H3⋯O8iii0.841.882.7104 (19)167
O71—H71⋯O2iv0.842.042.873 (4)172
O72—H72⋯O9i0.842.012.834 (5)169
O73—H73⋯O8v0.842.172.892 (6)144

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) ; (v) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  [Nephrolithiasis-induced ESRD: frequency, causes and prevention].

Authors:  Paul Jungers; Dominique Joly; Frédéric Barbey; Gabriel Choukroun; Michel Daudon
Journal:  Nephrol Ther       Date:  2005-10-03       Impact factor: 0.722

Review 3.  Kidney stones: pathophysiology and medical management.

Authors:  Orson W Moe
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

Review 4.  Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering.

Authors:  Hiroshi Ashihara; Hiroshi Sano; Alan Crozier
Journal:  Phytochemistry       Date:  2007-12-19       Impact factor: 4.072

5.  Racemic calcium tartrate tetrahydrate [form (II)] in rat urinary stones.

Authors:  A Le Bail; D Bazin; M Daudon; A Brochot; V Robbez-Masson; V Maisonneuve
Journal:  Acta Crystallogr B       Date:  2009-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.